Allergy Multi Symptom Tablet, Coated
NDC Package 46122-660-62
Package Information
Allergy Multi Symptom (acetaminophen, chlorpheniramine maleate, and phenylephrine hydrochloride) tablets is do not take more than directed (see overdose warning) adults and children 12 years and overtake 2 caplets every 4 hoursswallow whole; do not crush, chew, or dissolvedo not take more than 10 caplets in 24 hourschildren under 12 years ask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Amerisource Bergen, this product is identified by NDC 46122-660 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1046781 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1046781 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1046781 - APAP 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 46122 - Amerisource Bergen
- 46122-660 - Allergy Multi Symptom
- 46122-660-62 - 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK
- 46122-660 - Allergy Multi Symptom
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46122-660-62 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, coated in 1 blister pack of Allergy Multi Symptom, a human over the counter drug labeled by Amerisource Bergen. This tablet, coated is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amerisource Bergen on November 13, 2020. The current certification is valid through December 31, 2026.
How is this Amerisource Bergen product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46122066062. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.